One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made an interesting announcement. The healthcare company said that it will now offer branded Zepbound ...

Shares of Hims & Hers Health (NYSE: HIMS) are soaring as investors react to news about the company's partnership with Novo ...

Novo Nordisk, the maker of Wegovy, announced exclusively on " Good Morning America " Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Hims & Hers Health ... in the next 12-18 months to at least $50. 2024 Was Great, 2025 Gets Better On February 24, HIMS reported its Q4 and full-year results. Revenue of $1.5 billion was up ...

Patients will be able to access the popular GLP-1 through Novo Nordisk's online pharmacy, NovoCare, directly from Hims & Hers and telehealth providers Ro and LifeMD. In recent months, competitor ...

One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made an interesting announcement. The healthcare company said that it will now offer branded Zepbound ...